Ralph M. Bernstein

FDA investigator

Appears on 10 documents from 2019 to 2025, most often at sites in India. Most often cites written procedures; deviations (21 CFR 211.100).

10
Documents on file
6.7
Observations per 483
2019
First seen
2025
Most recent

What they cite most

From 64 observations

Activity by year

2019: 2, 2022: 5, 2024: 2, 2025: 1

Where

India 3 · South Korea 2 · Switzerland 2 · Denmark 1 · Germany 1 · Japan 1

Often inspects with

Zhong Li· Wayne Seifert· Arsen Karapetyan

Is Ralph M. Bernstein coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

10 documents, newest first
FirmOpen
483 Lonza AGOct 28, 2025 · Visp, Switzerland
483 Novo Nordisk A/SMar 25, 2024 · Kalundborg, Denmark
483 CELLTRION IncFeb 27, 2024 · Incheon, South Korea
483 Biocon Biologics LimitedAug 26, 2022 · Bengaluru, India
483 Biocon Biologics LimitedAug 26, 2022 · Bengaluru, India
483 Biocon Biologics LimitedAug 13, 2022 · Bengaluru, India
483 CELLTRION IncJun 3, 2022 · Incheon, South Korea

About this profile

What does Ralph M. Bernstein inspect?

Ralph M. Bernstein appears on 10 documents on file covering 7 sites, most often in India.

What do they cite most often?

21 CFR 211.100 (written procedures; deviations), followed by 21 CFR 211.160 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Ralph M. Bernstein is dated Oct 28, 2025.